Podcast Episodes
Back to SearchNEJM August 2026 Carbocisteine or Hypertonic Saline for Acute Respiratory Failure
This clinical study investigated whether two common medications, carbocisteine and hypertonic saline, could reduce the amount of time critically ill …
1 month, 3 weeks ago
NEJM August 2026 Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer
This clinical study investigates the effectiveness of selpercatinib, a targeted drug that blocks the RET protein, as a follow-up treatment for patien…
2 months ago
NEJM August 2026 In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
This study evaluates the clinical effectiveness of VERVE-102, a novel gene-editing treatment designed to combat high cholesterol by permanently alter…
2 months ago
NEJM August 2026 Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
This study investigates the efficacy of secukinumab, a monoclonal antibody, as a novel treatment for patients suffering from relapsed polymyalgia rhe…
2 months ago
NEJM August 2026 Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
This study investigates whether using a sirolimus-coated balloon during angioplasty offers better outcomes for patients with infrainguinal artery dis…
2 months ago
NEJM August 2026 Perioperative Apalutamide in High-Risk Localized Prostate Cancer
This clinical trial investigated whether adding the drug apalutamide to standard hormone therapy could improve outcomes for patients undergoing surge…
2 months ago
NEJM August 2026 Finerenone in Persons with Chronic Kidney Disease without Diabetes
This clinical study investigates whether the drug finerenone, previously proven effective for diabetic patients, can also protect the health of indiv…
2 months ago
NEJM July 2026 Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain.
This study investigates the efficacy of a novel drug designed to block pain signaling by targeting specific sodium channels in the nervous system. By…
2 months, 1 week ago
NEJM July 2026 PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
This study evaluates a novel treatment combination for patients with a specific form of advanced prostate cancer that remains sensitive to traditiona…
2 months, 1 week ago
NEJM July 2026 Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.
This study evaluates the effectiveness of teclistamab, a specialized bispecific antibody, as an early treatment option for patients facing a relapse …
2 months, 1 week ago